Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02511236Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Miami. Primary endpoints: The Number of Participants Reporting 7 Day Point Prevalence Abstinence at 12 months, Change in Perceived Stress Scores at 4 weeks and 1 more. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02511236.